Discussion about this post

User's avatar
Dr. Ken Springer's avatar

Supporting what you propose would be Journavx, the non-opiate analgesic the FDA just approved.

No idea how to pronounce the name, but the effectiveness data looks strong.

Expand full comment
2 more comments...

No posts